Therefore, while the association of OPRM1 with alcohol use disorder etiology remains controversial[26], findings suggest the relevance of OPRM1 for a phenotype of clinical interest: reduction in alcohol consumption during treatment with naltrexone versus placebo[19,35]. This evidence concerns the gene OPRM1 and alcohol abuse.